Sign In
Buy RVTY
$101.07
+0.680 (+0.677%)
At Close: Jun 03, 2026
Revitty (RVTY) Q3 2024 Earnings Call Transcript
12:30pm, Monday, 04'th Nov 2024
Revitty Incorporated (NYSE:RVTY ) Q3 2024 Earnings Conference Call November 4, 2024 8:00 AM ET Company Participants Prahlad Singh - President, Chief Executive Officer Max Krakowiak - Senior Vice Presi
Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings
10:35am, Monday, 04'th Nov 2024
Although the revenue and EPS for Revvity (RVTY) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Str
Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates
08:11am, Monday, 04'th Nov 2024
Revvity (RVTY) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.18 per share a year ago.
Revvity cuts 2024 revenue forecast amid biotech spending slowdown
07:55am, Monday, 04'th Nov 2024
Revvity cut its 2024 revenue forecast as reduced biotech spending and a strong dollar weigh on demand for its tools and services used in drug development.
Revvity Announces Financial Results for the Third Quarter of 2024
06:00am, Monday, 04'th Nov 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended September 29, 2024. The Company reported GAAP earnings per share of $0.77, as
Revvity to Report Q3 Earnings: What's in Store for the Stock?
02:16pm, Friday, 01'st Nov 2024
RVTY third-quarter results are likely to reflect decent performance in the Diagnostics segment, while the Life Sciences segment is likely to face continued challenges in China.
Earnings Preview: Revvity (RVTY) Q3 Earnings Expected to Decline
11:05am, Monday, 28'th Oct 2024
Revvity (RVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Revvity Board Declares Quarterly Dividend
04:05pm, Thursday, 24'th Oct 2024
WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on Febru
Revvity Shares Decline Despite Launch of Transcribe AI Solution
11:51am, Wednesday, 23'rd Oct 2024
RVTY introduces Transcribe AI that digitizes handwritten test request forms, improving workflow speed and reducing manual data entry errors.
Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report
08:00am, Tuesday, 22'nd Oct 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today unveils its annual Impact Report, a declaration of the Company's sustainability, social and governance strategy, initiatives and perfo
RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's Disease
11:00am, Thursday, 10'th Oct 2024
Revvity's latest solution for specific typing of AD-associated APOE gene is likely to allow assessment of a patient's risk for adverse effects from new anti-amyloid therapy for Alzheimer's.
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
12:35pm, Monday, 07'th Oct 2024
RVTY's continued focus on innovations and a strong product portfolio raise optimism about the stock.
Reasons to Retain Revvity Stock in Your Portfolio for Now
10:01am, Friday, 06'th Sep 2024
RVTY's strong product portfolio raises optimism about the stock.
MD or RVTY: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 26'th Aug 2024
Investors interested in Medical Services stocks are likely familiar with Pediatrix Medical Group (MD) and Revvity (RVTY). But which of these two stocks presents investors with the better value opportu
MD or RVTY: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 09'th Aug 2024
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Revvity (RVTY). But which of these two stocks presents investors with the better val
